Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
 

Showing results 80218 to 80237 of 162690 < previous   next >
B123_6Add1-fr.pdf.jpg
Partenariats mondiaux pour la santé : progrès concernant l’élaboration d’un projet de principes directeurs sur l’engagement de l’OMS : l'alliance GAVI : rapport du Secrétariat
Conseil exécutif, 123 ( 2008 )
B123_6-fr.pdf.jpg
Partenariats mondiaux pour la santé : progrès concernant l’élaboration d’un projet de principes directeurs sur l’engagement de l’OMS : rapport du Secrétariat
Conseil exécutif, 123 ( 2008 )
RA_2000_3_184-197_fre.pdf.jpg
Partenariats mondiaux public-privé : partie 1 - un nouveau développement dans le domaine de la santé? / K. Buse et G. Walt
Buse, Kent; Walt, G ( 2000 )
RA_2000_3_198-209_fre.pdf.jpg
Partenariats mondiaux public-privé: parti II : enjeux d' une gestion mondiale / K. Buse et G. Walt
Buse, Kent; Walt, G ( 2000 )
B134_42-fr.pdf.jpg
Partenariats pour la santé hébergés par l’OMS: Rapport du Secrétariat
Conseil exécutif, 134 ( 2014 )
fe8.pdf.jpg
Partenariats public-privé en faveur de la santé : Rapport du Directeur général
Conseil exécutif, 105 ( 2000 )
RA_2002_6_149-167_fre.pdf.jpg
Partenariats public-privé pour la santé : cibles, diversité et orientations futures / Roy Widdus
Widdus, Roy ( 2001 )
RA_2002_6_1-7_fre.pdf.jpg
Partenariats public-privé pour la santé : une stratégie pour l' OMS / Kent Buse et Amalia Waxman
Buse, Kent; Waxman, Amalia ( 2002 )
WHO_PHP_75_spa.pdf.jpg
La Partera tradicional en siete pa'ises : ejemplos pr'acticos de utilizaci'on y adiestramiento / edici'on preparada por A. Mangay-Maglacas y H. Pizurki
Mangay-Maglacas, Amelia; Pizurki, Helena; World Health Organization ( 1981 )
Parteras : profesionales por derecho propio / Sara Szmoisz y Rosa Vartabedian
Szmoisz, Sara; Vartabedian, Rosa ( 1992 )
9243561502_spa.pdf.jpg
Parteras tradicionales : declaración conjunta OMS/FNUAP/UNICEF
World Health Organization; United Nations Population Fund; UNICEF ( 1993 )
Abstract

En esta declaración conjunta OMS/FNUAP/UNICEF se vuelve a examinar la función que cabe esperar que desempeñen las parteras tradicionales por lo que se refiere a reducir la morbilidad y la mortalidad maternas. Dirigido a las personas que se encargan de formular políticas y a los planificadores, el folleto aspira a fomentar la adopción de decisiones realistas basadas en una clara comprensión de lo que las PT pueden y no pueden hacer y de la posi-bilidad de influir en sus puntos fuertes y sus limitaciones mediante los programas de forma-ción. En toda la obra, el recurso a las parteras tradicionales se considera una solución provisional en espera de alcanzar el más amplio objetivo de garantizar a todas las mujeres y niños el acceso a una atención sanitaria aceptable, profesional y moderna. La declaración se divide en ocho secciones. En las primeras se esclarece el papel real y potencial de las PT en la salud maternoinfantil y la planificación familiar. Tras definir breve-mente lo que se entiende por partera tradicional, PT de familia y PT adiestrada, se exponen las características de las diversas tareas que actualmente llevan a cabo las PT en diferentes contextos. Las secciones que siguen a esa información básica ofrecen consejos prácticos para los responsables de la adopción de decisiones, que pueden resultarles de utilidad a la hora de seleccionar las opciones más apropiadas para aplicar o reforzar los programas de PT. Se exponen las metas y objetivos de los programas de PT, y a continuación se resumen las doce medidas escalonadas que pueden adoptarse para aplicar un programa aprovechando todas las posibilidades de alcanzar sus objetivos. Una sección de considerable valor práctico es aquella en que se describen nueve aspectos (por ejemplo los relativos a la licencia para ejercer y la certificación, o al riesgo de transmisión del VIH) que indefectiblemente se plantean cada vez que hay que adoptar decisiones sobre un determinado programa. En las secciones restantes se advierte a los lectores de las limitaciones de los programas de formación de PT, incluida su insuficiencia, cuando se utilizan como método único, para mejorar la atención maternoinfantil, y se examinan las perspectivas futuras de las PT adiestradas y supervisadas, en el contexto de la tendencia a dar a las mujeres acceso a una asistencia sanitaria moderna y a los servicios de parteras profesionales o médicos. Con ser importante este último objetivo, el folleto acaba señalando que siempre será necesario preservar lo mejor de la asistencia que prestan las PT: la dedicación abnegada, el sentimiento humanitario y la respuesta a las necesidades culturales y espirituales

Parteras tradicionales : guía práctica para el adiestramiento, la evaluación y la articulación de este personal en los servicios de salud / participantes en la preparación del volumen, Beverley du Gas ... [et al.]
Du Gas, Beverley; Mangay-Maglacas, Amelia; Pizurki, Helena; Simons, John; World Health Organization ( 1979 )
Parteras tradicionales adiestradas instruyen a madres refugiadas / Laurie C. Miller ... [et al.]
Miller, Laurie C; Jami-Imam, Fahima; Timouri, Masouma; Wijnker, Jelleke ( 1995 )
Las parteras tradicionales pueden identificar a las madres y a los niños expuestos / A. Alisjahbana, R. Peeters y A. Meheus
Alisjahbana, Anna; Peeters, R; Meheus, André Z ( 1986 )
WHO_Mal_71.746.pdf.jpg
Partial exophily of Anopheles gambiae species B in Khashm Elgirba Medto area in Eastern Sudan A. M. Haridi
Haridi, A. M; World Health Organization ( 1971 )
2012_18_7_0755_0761.pdf.jpg
Partial hydatidiform mole in Morocco: an epidemiological and clinical study
Boufettal, H.; Coullin, P.; Mahdaoui, S.; Noun, M.; Hermas, S.; Samouh, N. ( 2012 )
Abstract

This retrospective study reviewed cases of partial hydatidiform mole [PHM] diagnosed at the University Hospital in Casablanca from 2000 to 2010 in order to examine the epidemiological, clinical, therapeutic and progressive pathological factors associated with PHM. All PHM cases confirmed clinically and sonographically at pathological examination were included. We identified 24 cases of PHM among 60 748 births and 1704 abortions, giving a frequency of 0.4 per 1000 pregnancies and 1.4% of abortions. The mean age was 26 years [range: 16-55 years]. The circumstances of discovery and clinical ultrasound varied: 79.2% of patients sought consultation for bleeding; clinical thyrotoxicosis syndrome was found in 1 patient [4.2%]. Physical examination showed increased uterine size in 83.3% of cases associated with a latero-uterine mass in 25%. The diagnosis was supported by an ultrasound examination combined with measurement of plasma beta HCG. Histological confirmation was made in all cases and treatment was endo-uterine aspiration. Neoplastic drift was observed in 1 case [4.2%] which went into remission with chemotherapy

WHO_VBC_74.490_eng.pdf.jpg
Partial loss of cytoplasmic incompatibility with age in males of culex fatigans
Singh, K.R.P; Curtis, C.F.; Krishnamurthy, B.S.; World Health Organization ( 1974 )
Partially halogenated chlorofluorocarbons (ethane derivatives / published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization
World Health Organization; International Programme on Chemical Safety ( 1992 )
Abstract

Evaluates the environmental behaviour, toxicity, and ozone-depleting and global-warming potentials of six partially halogenated ethane derivatives selected as candidates to replace the fifteen fully halogenated chlorofluorocarbons that are being phased out in line with the provisions of the Montreal Protocol on Substances that Deplete the Ozone Layer. The compounds considered are 1,1-dichloro-1-fluoroethane (HCFC 141b), 1-chloro1,1-difluoroethane (HCFC 142b), 1,2-dichloro-1,1-difluoroethane (HCFC 132b), 1-chloro-2,2,2-trifluoroethane (HCFC 133a), 1,1-dichloro-2,2,2-trifluoroethane (HCFC 123), and 1-chloro-1,2,2,2-tetrafluoroethane (HCFC 124). All compounds were judged to have ozone-depleting and global-warming potentials considerably lower than those of CFC 11, the fully halogenated chlorofluorocarbon with the highest ozone-depleting and global-warming potentials. Estimated atmospheric lifetimes range from 1.6 years for HCFC 123 to 19.1 years for HCFC 142b. Because studies of HCFC 132b and HCFC 133a have documented a number of toxic effects, these compounds could not be recommended as substitutes. Since the toxicity of HCFC 142b is low and the ozone-depleting and global-warming potentials are lower than those of the fully halogeated chlorofluorocarbons, the report concludes that HCFC 142b can be considered as a transient substitute for the chlorofluorocarbons included in the Montreal Protocol. In view of the paucity of toxicological data on HCFC 141b, HCFC 123, and HCFC 125, no evaluation of their potential effects on human health could be made

Partially halogenated chlorofluorocarbons (methane derivatives / published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization
World Health Organization; International Programme on Chemical Safety ( 1991 )
Abstract

Evaluates the risks to human health and the environment posed by two partially halogenated chlorofluorocarbons: dichlorofluoromethane (HCFC 21) and chlorodifluoromethane (HCFC 22). These two methane derivatives were selected for evaluation because of their potential use as substitutes for those fully halogenated chlorofluorocarbons that are being phased out as a result of the 1987 Montreal Protocol on Substances that Deplete the Ozone Layer. The evaluation is intended to assist industry in its urgent search for acceptable substitute chemicals, most notably for use as refrigerants, as propellants in aerosols, and as blowing agents for the production of polystyrene. While data on human toxicity are thoroughly reviewed, the greatest challenge is to find the most accurate models for predicting levels of release to the environment and estimating the potential of these chemicals to deplete the ozone layer. Because HCFC 21 is no longer produced for any commercial purposes, most data assessed come from studies of HCFC 22. Current environmental levels of both chemicals are judged to be extremely low and highly unlikely to cause direct effects on human health. A review of models for estimating atmospheric residence times and routes of transport to the stratosphere concludes that the ozone-depleting potential of both chemicals is considerably lower than that of the fully halogenated chlorofluorocarbons. While HCFC 21 has the advantage of a much shorter tropospheric lifetime, studies have linked exposure to liver damage. Concerning the toxicity of HCFC 22, evidence from the vast majority of studies is reassuring. The report concludes that HCFC 22 is an acceptable transient substitute for the chlorofluorocarbons included in the Montreal Protocol. HCFC 21 could not be recommended as a substitute in view of its potential toxic effects on the liver

Participaci'on comunitaria en la investigaci'on y acci'on contra el alcoholismo / Abhay T. Bang y Rani A. Bang
Bang, Abhay T; Bang, Rani A ( 1991 )
Showing results 80218 to 80237 of 162690 < previous   next >